1. Home
  2. NEON vs GTBP Comparison

NEON vs GTBP Comparison

Compare NEON & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

N/A

Current Price

$0.95

Market Cap

15.1M

Sector

Technology

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

N/A

Current Price

$15.11

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEON
GTBP
Founded
1997
1965
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1M
13.0M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
NEON
GTBP
Price
$0.95
$15.11
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
98.8K
423.4K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
3.75
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.26
52 Week High
$25.90
$1.37

Technical Indicators

Market Signals
Indicator
NEON
GTBP
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NEON
GTBP

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: